Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Services
Return to: PBR Home | Contract Research & Services | Contract Services

Contract Services

Avadel secures exclusive rights to nocturia candidate Noctiva in US and Canada Avadel Pharmaceuticals has entered into a license agreement with Serenity Pharmaceuticals, which grants Avadel the sole right to commercialize and further develop Noctiva in the US and Canada.
Contract Research & Services > Contract Services > News
Ligand to receive $2m from WuXi for licensing clinical-stage anti-PD-1 antibody Ligand Pharmaceuticals will get a payment of $2m from WuXi Biologics subsequent to their licensing of exclusive rights to the anti-PD-1 antibody GLS-010 to Arcus Biosciences in North America, Europe, Japan and other selected territories.
Contract Research & Services > Contract Services > News Oxford BioMedica secures commercial supply licence from UK MHRA Oxford BioMedica has been granted a Manufacturer/Importer License (MIA) from the UK Medicines and Healthcare products Regulatory Agency (MHRA), to manufacture and distribute lentiviral vector material for commercial supply.
Contract Research & Services > Contract Services > News
See more Contract Services news

Latest Contract Services News and Insight

View all Contract Services news or find news targeted to your interests
Avadel secures exclusive rights to nocturia candidate Noctiva in US and Canada
Avadel Pharmaceuticals has entered into a license agreement with Serenity Pharmaceuticals, which grants Avadel the sole right to commercialize and further develop Noctiva in the US and Canada.
Contract Research & Services > Contract Services > News
Ligand to receive $2m from WuXi for licensing clinical-stage anti-PD-1 antibody
Ligand Pharmaceuticals will get a payment of $2m from WuXi Biologics subsequent to their licensing of exclusive rights to the anti-PD-1 antibody GLS-010 to Arcus Biosciences in North America, Europe, Japan and other selected territories.
Contract Research & Services > Contract Services > News
NSF International Adds Pharma Biotech Services to India Office
NSF’s pharma biotech experts now serving India’s pharmaceutical industry from Gurugram office
Contract Research & Services > Contract Services > Press Releases
Oxford BioMedica secures commercial supply licence from UK MHRA
Oxford BioMedica has been granted a Manufacturer/Importer License (MIA) from the UK Medicines and Healthcare products Regulatory Agency (MHRA), to manufacture and distribute lentiviral vector material for commercial supply.
Contract Research & Services > Contract Services > News
View all Contract Services news or find news targeted to your interests